Is Beyond Medical Stock a Good Investment?
Beyond Medical Investment Advice | DOCKF |
- Examine Beyond Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Beyond Medical's leadership team and their track record. Good management can help Beyond Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Industrial Machinery & Supplies & Components space and any emerging trends that could impact Beyond Medical's business and its evolving consumer preferences.
- Compare Beyond Medical's performance and market position to its competitors. Analyze how Beyond Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Beyond Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Beyond Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Beyond Medical Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Beyond Medical Technologies is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Beyond Medical Stock
Researching Beyond Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 24.0% of the company shares are held by company insiders. The company last dividend was issued on the 12th of May 2020. Beyond Medical Techn had 1:10 split on the 30th of December 2022.
To determine if Beyond Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Beyond Medical's research are outlined below:
| Beyond Medical Techn is way too risky over 90 days horizon | |
| Beyond Medical Techn has some characteristics of a very speculative penny stock | |
| Beyond Medical Techn appears to be risky and price may revert if volatility continues | |
| Beyond Medical Techn has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (285.94 K) with loss before overhead, payroll, taxes, and interest of (250.49 K). | |
| Beyond Medical Technologies has accumulated about 877.31 K in cash with (109.77 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Beyond Medical Techn has a frail financial position based on the latest SEC disclosures | |
| Roughly 24.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Beyond Medical Technologies Announces Corporate Name Change to Republic Technologies DOCKF ... |
Beyond Medical Quarterly Accounts Payable |
|
Beyond Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.8 M.Market Cap |
|
Beyond Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (7.17) | (6.81) | |
| Return On Capital Employed | 1.77 | 1.85 | |
| Return On Assets | (7.17) | (6.81) | |
| Return On Equity | 2.05 | 2.15 |
Determining Beyond Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Beyond Medical is a good buy. For example, gross profit margin measures Beyond Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Beyond Medical's profitability and make more informed investment decisions.
Evaluate Beyond Medical's management efficiency
Beyond Medical Techn has return on total asset (ROA) of (1.3464) % which means that it has lost $1.3464 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8854) %, meaning that it generated substantial loss on money invested by shareholders. Beyond Medical's management efficiency ratios could be used to measure how well Beyond Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Beyond Medical's Return On Capital Employed is most likely to increase slightly in the upcoming years. The Beyond Medical's current Return On Equity is estimated to increase to 2.15, while Return On Tangible Assets are forecasted to increase to (6.81). At this time, Beyond Medical's Fixed Asset Turnover is most likely to increase in the upcoming years.| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (11.91) | (11.31) | |
| Book Value Per Share | (0.05) | (0.04) | |
| Tangible Book Value Per Share | (0.05) | (0.04) | |
| Price Book Value Ratio | (1.15) | (1.09) | |
| Enterprise Value Multiple | (11.91) | (11.31) | |
| Price Fair Value | (1.15) | (1.09) | |
| Enterprise Value | 24.7 K | 27.9 K |
Understanding the management dynamics of Beyond Medical Technologies allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Beta 7.7 K |
Basic technical analysis of Beyond Stock
As of the 18th of July 2025, Beyond Medical shows the Mean Deviation of 7.91, standard deviation of 31.66, and Risk Adjusted Performance of 0.1302. Beyond Medical Techn technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Beyond Medical Techn standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if Beyond Medical Techn is priced correctly, providing market reflects its regular price of 0.28 per share. As Beyond Medical Techn appears to be a penny stock we also recommend to validate its information ratio numbers.Understand Beyond Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Beyond Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1302 | |||
| Market Risk Adjusted Performance | (1.86) | |||
| Mean Deviation | 7.91 | |||
| Coefficient Of Variation | 776.47 | |||
| Standard Deviation | 31.66 | |||
| Variance | 1002.6 | |||
| Information Ratio | 0.1238 | |||
| Jensen Alpha | 4.39 | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (1.87) | |||
| Maximum Drawdown | 257.14 | |||
| Skewness | 8.1 | |||
| Kurtosis | 65.7 |
| Risk Adjusted Performance | 0.1302 | |||
| Market Risk Adjusted Performance | (1.86) | |||
| Mean Deviation | 7.91 | |||
| Coefficient Of Variation | 776.47 | |||
| Standard Deviation | 31.66 | |||
| Variance | 1002.6 | |||
| Information Ratio | 0.1238 | |||
| Jensen Alpha | 4.39 | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (1.87) | |||
| Maximum Drawdown | 257.14 | |||
| Skewness | 8.1 | |||
| Kurtosis | 65.7 |
Consider Beyond Medical's intraday indicators
Beyond Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Beyond Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Beyond Medical time-series forecasting models is one of many Beyond Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Beyond Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Beyond Stock media impact
There is far too much social signal, news, headlines, and media speculation about Beyond Medical that are available to investors today. This information is accessible both publicly - through Beyond Medical's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Beyond-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Beyond Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Beyond Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Beyond Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Beyond Medical alpha.
Beyond Medical Corporate Management
| Stevenson Ty | Interim Officer | Profile | |
| Kulwant Malhi | Chairman CEO | Profile | |
| CPA CGA | Chief Officer | Profile | |
| Karen Lauriston | Community Investor | Profile | |
| Litong Cao | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Beyond Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.